NI YONG,PARIKH BHAVNISH,YELESWARAM KRISHNASWAMY,ERICKSON VIITANEN SUSAN,WILLIAMS WILLIAM V
申请号：
IN5153/DELNP/2015
公开号：
IN2015DN05153A
申请日:
2015.06.12
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention relates to sustained -release formulations and dosage forms of ruxolitinib , or a pharmaceutically acceptable salt thereof , which are useful in the treatment of Janus kinase -associated diseases such as myeloproliferative disorders.
